Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma

Conference paper

Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S257 - S257

Estimating risk of radiation toxicity for lymphoma patients using pre-chemotherapy PET-CT scans

Conference paper

Shakir R. et al, (2022), RADIOTHERAPY AND ONCOLOGY, 170, S253 - S255

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

Journal article

Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma.

Journal article

Way A. et al, (2022), Int J Part Ther, 8, 76 - 81

Predicted cardiac and second cancer risks following treatment for Hodgkin lymphoma in Ireland

Conference paper

Houlihan O. et al, (2021), RADIOTHERAPY AND ONCOLOGY, 161, S900 - S901

Limited-stage diffuse large B-cell lymphoma: current management and challenges.

Journal article

Zhang X-Y. et al, (2021), Br J Haematol

An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most?

Conference paper


Pleural plasmacytomas - the role of radiotherapy.

Journal article

Yeoh K-W. et al, (2020), Br J Haematol

Twenty five year risks of breast cancer mortality in 500,000 women

Conference paper

Taylor C. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 589 - 589

Cardiovascular and Pulmonary Late Effects.


Aleman BMP. and Cutter D., (2020), Hodgkin Lymphoma

Load More